Proassurance CORP Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Proassurance CORP share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Banks sector, Proassurance CORP has published 205 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 26 June 2026 (Disposition). Among the most active insiders: COBARRUBIAS FABILOA. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,253 of 29,062 companies
FCF yld -2.3%
Earn yld 3.9%
EV/EBITDA 12.2x
ROE 5.1%
Gross mgn ·
Net mgn 4.7%
Debt/EBITDA 3.1x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 June 2026
All Executives205 Thresholds0 Prospectus0 Other0
Declarations 205 total
● Director · Executives · 26 Jun 2026
35,652 shares Common Stock SEC:0001672854-26-000002:0
● Director · Executives · 26 Jun 2026
10,621 shares Common Stock SEC:0001192254-26-000004:0
● Director · Executives · 26 Jun 2026
25,184 shares Common Stock SEC:0001862104-26-000002:0
● Director · Executives · 26 Jun 2026
39,386 shares Common Stock SEC:0001478420-26-000004:0
● Director · Executives · 26 Jun 2026
5,566 shares Common Stock SEC:0001478420-26-000004:1
● Executive VP/Chief HR Officer · Executives · 26 Jun 2026
27,868 shares Common Stock SEC:0001831953-26-000006:0
● Pres Healthcare Pro. Liability · Executives · 26 Jun 2026
31,196 shares Common Stock SEC:0001983910-26-000006:0
● Director · Executives · 26 Jun 2026
31,298 shares Common Stock SEC:0001776616-26-000002:0
● Chief Financial Officer · Executives · 26 Jun 2026
45,392 shares Common Stock SEC:0001750737-26-000006:0
● Executive Vice-President · Executives · 26 Jun 2026
98,066 shares Common Stock SEC:0001347604-26-000012:0
◇ Pres Healthcare Pro. Liability · Executives · 25 Feb 2026
3,226 shares @ US$24.47 25.0% of flow Common Stock SEC:0001983910-26-000004:0
◇ Executive VP/Chief HR Officer · Executives · 25 Feb 2026
3,101 shares @ US$24.47 24.4% of flow Common Stock SEC:0001831953-26-000004:0
◇ Chief Financial Officer · Executives · 25 Feb 2026
3,981 shares @ US$24.47 12.7% of flow Common Stock SEC:0001750737-26-000004:0
◇ President of a Subsidiary · Executives · 25 Feb 2026
3,981 shares @ US$24.47 15.0% of flow Common Stock SEC:0001352241-26-000003:0
◇ Executive Vice-President · Executives · 25 Feb 2026
3,981 shares @ US$24.47 15.7% of flow Common Stock SEC:0001347604-26-000010:0
◇ President & CEO · Executives · 25 Feb 2026
18,435 shares @ US$24.47 17.0% of flow Common Stock SEC:0001307649-26-000004:0
◇ Executive VP/Chief HR Officer · Executives · 23 May 2025
5,987 shares @ US$23.15 28.0% of flow Common Stock SEC:0001704084-25-000039:0
● Executive VP/Chief HR Officer · Executives · 23 May 2025
2,485 shares @ US$23.15 11.6% of flow Common Stock SEC:0001704084-25-000039:1
◇ Pres Healthcare Pro. Liability · Executives · 23 May 2025
8,765 shares @ US$23.15 34.3% of flow Common Stock SEC:0001704084-25-000040:0
● Pres Healthcare Pro. Liability · Executives · 23 May 2025
3,712 shares @ US$23.15 14.5% of flow Common Stock SEC:0001704084-25-000040:1
◇ Chief Financial Officer · Executives · 23 May 2025
7,686 shares @ US$23.15 18.0% of flow Common Stock SEC:0001704084-25-000042:0
● Chief Financial Officer · Executives · 23 May 2025
3,256 shares @ US$23.15 7.6% of flow Common Stock SEC:0001704084-25-000042:1
◇ Executive Vice-President · Executives · 23 May 2025
7,686 shares @ US$23.15 21.0% of flow Common Stock SEC:0001704084-25-000043:0
● Executive Vice-President · Executives · 23 May 2025
3,256 shares @ US$23.15 8.9% of flow Common Stock SEC:0001704084-25-000043:1
◇ President of a Subsidiary · Executives · 23 May 2025
7,686 shares @ US$23.15 20.3% of flow Common Stock SEC:0001704084-25-000041:0
25 of 205 declarations
Load more (180 remaining) 关于 Proassurance CORP ProAssurance Corp.(股票代码PRA)是一家总部位于美国的专业保险公司,在美国纽约证券交易所上市,其核心业务是职业责任险。公司总部位于阿拉巴马州伯明翰,作为一家财产和意外保险控股公司运营,致力于保护面临复杂责任风险的专业人士,特别是在医疗保健领域。其目前的法人结构可追溯到2001年,当时Medical Assurance, Inc.和Professionals Group, Inc.合并,尽管管理层也强调该业务起源于1970年代医疗责任危机中由医生主导的应对措施。([s205.q4cdn.com](https://s205.q4cdn.com/588102317/files/doc_financials/2025/q4/PRA-2025-12-31-10K-FINAL.pdf))
ProAssurance的运营模式以医疗专业责任保险为核心,主要通过一组子公司承保,包括ProAssurance Indemnity Company、ProAssurance Casualty Company、Norcal Insurance Company、ProAssurance Insurance Corporation of America (PICA)和ProAssurance Specialty Insurance Company。公司还通过Medmarc承保医疗技术和生命科学产品责任险,通过多家子公司承保法律专业责任险,并通过Eastern Alliance Insurance Group承保工人赔偿险。这种组合使PRA能够接触到医生、医疗机构、生命科学公司和其他需要量身定制风险解决方案而非商品化商业险的专业服务提供商。([investor.proassurance.com](https://investor.proassurance.com/corporate-profile/default.aspx))
从竞争角度来看,ProAssurance在一个分散且周期性的财产和意外险市场中运营,其中承保纪律、理赔处理、财务实力、地方关系和专业知识至关重要。该集团强调其多家运营子公司获得了A(优秀)的A.M. Best评级,这是专业保险领域的重要差异化因素。在其2025年报告中,ProAssurance表示其净保费收入约为0.9 billion美元,总资产为5.4 billion美元,股东权益为1.3 billion美元,这突显了对于一家利基保险公司而言,其拥有坚实的资产负债表基础。([investor.proassurance.com](https://investor.proassurance.com/corporate-profile/default.aspx))
从地理上看,该业务绝大部分集中在美国。ProAssurance的行政办公室位于阿拉巴马州伯明翰,并在密歇根州奥克莫斯设有办事处。因此,其业务主要集中在美国,跨越多个州的监管体系,而不是围绕广泛的国际足迹构建。该股票在纽约证券交易所交易,股票代码为PRA,使其成为筛选美国上市专业保险公司的投资者所熟悉的公司。([s205.q4cdn.com](https://s205.q4cdn.com/588102317/files/doc_financials/2025/q4/PRA-2025-12-31-10K-FINAL.pdf))
最近的发展主要围绕The Doctors Company的待定收购。2025年3月,双方宣布达成最终协议,The Doctors Company将以每股25.00美元现金收购ProAssurance。股东于2025年6月批准了该交易,HSR等待期于2025年7月提前终止,截至2026年2月23日,已获得多项保险监管批准,其他批准仍在等待中。管理层目前预计不迟于2026年6月30日完成交易。因此,对于投资者而言,该公司正处于交易的后期阶段,这可能在交易完成前仍是主要的市场叙事。([proassurancegroup.com](https://proassurancegroup.com/tdc))